On December 27, INNOCARE (09969) spent HK$599,000 to repurchase 100,000 shares.

date
27/12/2024
avatar
GMT Eight
INNOCARE (09969) announced that on December 27, 2024, it spent HK$599,000 to repurchase 100,000 shares.
pre
China Zheshang Bank (601916.SH) intends to increase the capital of its subsidiary Zhejiang Silver Gold Lease by no more than 1.02 billion yuan.
Hong Kong's average wage rate in September increased by 3.6% year-on-year.
next

RECOMMEND

recommend

Subsidiary Guangzhou Baiyunshan Pharmaceutical Holdings' traditional Chinese medicine division has obtained a notification letter for drug clinical trial approval.

date
10 min ago
recommend

Guangzhou Baiyunshan Pharmaceutical Holdings (00874) subsidiary has received the "Drug Clinical Trial Approval Notice" issued by the National Medical Products Administration.

date
11 min ago
recommend

Subsidiary of Guangzhou Baiyunshan Pharmaceutical Holdings, Guangzhou Baiyunshan Pharmaceutical Holdings Chinese Medicine, has received the notice of approval for clinical trials of drugs.

date
12 min ago

©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.

Contact: contact@gmteight.com